ZTS 39.99 Zoetis Inc. Class A Common Stoc $ZTS Hit a 52 week high of 40.25 Currently at 39.99 -0.17 -0.42% With a day low of 39.95 and a total volume of 433,553.
ZTS Zoetis Inc. Class A Common Stoc Recent Headline News
Zoetis (ZTS) Stock Jumps After William Ackman Takes Stake
at The Street - 16 mins ago
Zoetis (ZTS) is gaining Tuesday following reports that activist investor William Ackman has taken a stake in the animal health company.
ZTS: 43.30 (+3.14)
Zoetis jumps 6% on report of Ackman stake
Seeking Alpha - at Seeking Alpha - 19 mins ago
ZTS: 43.30 (+3.14), VRX: 129.83 (+1.84)
These Statistics Demonstrate the Staggering and Undeniable Power of Pets
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 1:41PM CST
Source: Flickr user Brad Holt. Pet ownership may not be for everyone, but it's becoming more prominent than you might have first thought. According to the American Pet Products Association, or APPA, pet ownership by household in the U.S. has...
ZTS: 43.30 (+3.14), PETS: 13.62 (+0.07), WOOF: 46.23 (-0.15), PETM: 72.66 (-0.08)
Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST
ZTS: 43.30 (+3.14), ACT: 243.95 (-1.78), MYL: 53.59 (-0.36)
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna
PR Newswire - Fri Nov 07, 7:55AM CST
Today, Analysts Review released its research reports regarding Medtronic, Inc. (NYSE: MDT), Zoetis Inc. (NYSE: ZTS), Biogen Idec Inc. (NASDAQ: BIIB), Tenet Healthcare Corp. (NYSE: THC) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7776-100free.
ZTS: 43.30 (+3.14), BIIB: 324.58 (-3.29), MDT: 69.01 (+0.30), THC: 48.24 (+0.21), AET: 84.54 (+0.52)
Zoetis to Participate in Piper Jaffray 26th Annual Healthcare Conference
Business Wire - Wed Nov 05, 7:30AM CST
Zoetis Inc.(NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST.
ZTS: 43.30 (+3.14)
Zoetis (ZTS) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Nov 04, 6:36PM CST
The following Zoetis (ZTS) conference call took place on November 4, 2014, 08:30 AM ET. This is a transcript of that earnings call:
ZTS: 43.30 (+3.14)
Zoetis' (ZTS) CEO Juan Alaix on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:20PM CST
ZTS: 43.30 (+3.14)
Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:50AM CST
Zoetis' (ZTS) third-quarter 2014 earnings (excluding special items) of 41 cents per share were above the Zacks Consensus Estimate of 37 cents.
ZTS: 43.29 (+3.13), ENDP: 68.10 (-0.77), VRX: 129.83 (+1.84), PFE: 30.31 (+0.11)
Zoetis beats 3Q profit forecasts
AP - Tue Nov 04, 8:33AM CST
FLORHAM PARK, N.J. (AP) — FLORHAM PARK, N.J. (AP) — Zoetis Inc. (ZTS) on Tuesday reported third-quarter profit of $166 million.
ZTS: 43.29 (+3.13)
Zoetis Reports Third Quarter 2014 Results
Business Wire - Tue Nov 04, 6:03AM CST
--Third Quarter 2014 Reported Net Income of $166 Million, or Diluted EPS of $0.33, Increased 27%, Compared to Third Quarter 2013
ZTS: 43.29 (+3.13)
Zoetis beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:02AM CST
ZTS: 43.29 (+3.13)
Zoetis (ZTS) Stock Gains Ahead of Third-Quarter Earnings Report
at The Street - Mon Nov 03, 2:52PM CST
Shares of Zoetis (ZTS) are gaining Monday ahead of the drug manufacturer's third-quarter earnings report before the market's open on Tuesday.
ZTS: 43.28 (+3.12)
Will Zoetis (ZTS) Pull a Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 4:10PM CDT
Zoetis Inc. (ZTS) is scheduled to report third-quarter 2014 results before the opening bell on Nov 4.
ZTS: 43.29 (+3.13), ACT: 244.02 (-1.71), PFE: 30.31 (+0.11), HSP: 57.49 (+1.51)
A Future Dividend Champion - Zoetis
DG Ruralist - at Seeking Alpha - Sat Oct 25, 6:22PM CDT
ZTS: 43.29 (+3.13), PFE: 30.31 (+0.11)
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
at The Street - Wed Oct 22, 10:36AM CDT
Amgen plans to expound on plans for the company at its Oct. 28 investor meeting.
ZTS: 43.30 (+3.14), ABT: 44.23 (+0.14), PFE: 30.32 (+0.12), AMGN: 162.38 (-0.71), ABBV: 63.80 (+0.01)
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt
PR Newswire - Mon Oct 20, 7:40AM CDT
Investor-Edge has initiated coverage on the following equities: Allergan Inc. (NYSE: AGN), Zoetis Inc. (NYSE: ZTS), Actavis PLC (NYSE: ACT), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), and Mallinckrodt PLC (NYSE: MNK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 17, 2014, the NASDAQ Composite ended at 4,258.44, up 0.97%, the Dow Jones Industrial Average advanced 1.63%, to finish the day at 16,380.41, and the S&P 500 closed at 1,886.76, up 1.29%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 707.88, up 1.61%, with the index also advancing 0.29% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
MNK: 93.65 (+0.42), ZTS: 43.29 (+3.13), AGN: 195.82 (+0.58), AVNR: 13.32 (+0.10), ACT: 244.02 (-1.71)
Approval of Settlement, Philanthropic Activities, Partnership, Market Activity, and Dividend - Research Reports on Duke Energy, Lowe's, Viacom, Trinity and Zoetis
PR Newswire - Wed Oct 08, 8:20AM CDT
Today, Analysts Review released its research reports regarding Duke Energy Corp. (NYSE: DUK), Lowe's Companies, Inc. (NYSE: LOW), Viacom, Inc. (NASDAQ: VIAB), Trinity Industries Inc. (NYSE: TRN) and Zoetis Inc. (NYSE: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7017-100free.
ZTS: 43.28 (+3.12), DUK: 82.59 (-0.22), TRN: 35.98 (-0.04), LOW: 57.99 (+0.16), VIAB: 69.49 (-0.60)
Zoetis' board announces dividend of USD0.072 per share for Q4 2014
M2 - Fri Oct 03, 4:23AM CDT
The board of directors of Zoetis (NYSE:ZTS), an animal health company, on Friday declared a fourth quarter dividend of USD0.072 per share of the company's common stock.
ZTS: 43.28 (+3.12)
Zoetis Declares Fourth Quarter 2014 Dividend
Business Wire - Thu Oct 02, 4:10PM CDT
The Board of Directors of Zoetis Inc.(NYSE:ZTS) declared a fourth quarter dividend payable to holders of the company's common stock of $0.072 per share. The dividend is to be paid on Tuesday, Dec. 2, 2014, to holders of record on Wednesday, Nov. 5, 2014.
ZTS: 43.30 (+3.14)
ZTS Zoetis Inc. Class A Common Stoc Recent Headline News
Zoetis (ZTS) Stock Jumps After William Ackman Takes Stake
at The Street - 16 mins ago
Zoetis (ZTS) is gaining Tuesday following reports that activist investor William Ackman has taken a stake in the animal health company.
ZTS: 43.30 (+3.14)
Zoetis jumps 6% on report of Ackman stake
Seeking Alpha - at Seeking Alpha - 19 mins ago
ZTS: 43.30 (+3.14), VRX: 129.83 (+1.84)
These Statistics Demonstrate the Staggering and Undeniable Power of Pets
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 1:41PM CST
Source: Flickr user Brad Holt. Pet ownership may not be for everyone, but it's becoming more prominent than you might have first thought. According to the American Pet Products Association, or APPA, pet ownership by household in the U.S. has...
ZTS: 43.30 (+3.14), PETS: 13.62 (+0.07), WOOF: 46.23 (-0.15), PETM: 72.66 (-0.08)
Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST
ZTS: 43.30 (+3.14), ACT: 243.95 (-1.78), MYL: 53.59 (-0.36)
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna
PR Newswire - Fri Nov 07, 7:55AM CST
Today, Analysts Review released its research reports regarding Medtronic, Inc. (NYSE: MDT), Zoetis Inc. (NYSE: ZTS), Biogen Idec Inc. (NASDAQ: BIIB), Tenet Healthcare Corp. (NYSE: THC) and Aetna Inc. (NYSE: AET). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7776-100free.
ZTS: 43.30 (+3.14), BIIB: 324.58 (-3.29), MDT: 69.01 (+0.30), THC: 48.24 (+0.21), AET: 84.54 (+0.52)
Zoetis to Participate in Piper Jaffray 26th Annual Healthcare Conference
Business Wire - Wed Nov 05, 7:30AM CST
Zoetis Inc.(NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST.
ZTS: 43.30 (+3.14)
Zoetis (ZTS) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Nov 04, 6:36PM CST
The following Zoetis (ZTS) conference call took place on November 4, 2014, 08:30 AM ET. This is a transcript of that earnings call:
ZTS: 43.30 (+3.14)
Zoetis' (ZTS) CEO Juan Alaix on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:20PM CST
ZTS: 43.30 (+3.14)
Zoetis Q3 Earnings Beat Driven by Higher Livestock Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:50AM CST
Zoetis' (ZTS) third-quarter 2014 earnings (excluding special items) of 41 cents per share were above the Zacks Consensus Estimate of 37 cents.
ZTS: 43.29 (+3.13), ENDP: 68.10 (-0.77), VRX: 129.83 (+1.84), PFE: 30.31 (+0.11)
Zoetis beats 3Q profit forecasts
AP - Tue Nov 04, 8:33AM CST
FLORHAM PARK, N.J. (AP) — FLORHAM PARK, N.J. (AP) — Zoetis Inc. (ZTS) on Tuesday reported third-quarter profit of $166 million.
ZTS: 43.29 (+3.13)
Zoetis Reports Third Quarter 2014 Results
Business Wire - Tue Nov 04, 6:03AM CST
--Third Quarter 2014 Reported Net Income of $166 Million, or Diluted EPS of $0.33, Increased 27%, Compared to Third Quarter 2013
ZTS: 43.29 (+3.13)
Zoetis beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:02AM CST
ZTS: 43.29 (+3.13)
Zoetis (ZTS) Stock Gains Ahead of Third-Quarter Earnings Report
at The Street - Mon Nov 03, 2:52PM CST
Shares of Zoetis (ZTS) are gaining Monday ahead of the drug manufacturer's third-quarter earnings report before the market's open on Tuesday.
ZTS: 43.28 (+3.12)
Will Zoetis (ZTS) Pull a Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 4:10PM CDT
Zoetis Inc. (ZTS) is scheduled to report third-quarter 2014 results before the opening bell on Nov 4.
ZTS: 43.29 (+3.13), ACT: 244.02 (-1.71), PFE: 30.31 (+0.11), HSP: 57.49 (+1.51)
A Future Dividend Champion - Zoetis
DG Ruralist - at Seeking Alpha - Sat Oct 25, 6:22PM CDT
ZTS: 43.29 (+3.13), PFE: 30.31 (+0.11)
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
at The Street - Wed Oct 22, 10:36AM CDT
Amgen plans to expound on plans for the company at its Oct. 28 investor meeting.
ZTS: 43.30 (+3.14), ABT: 44.23 (+0.14), PFE: 30.32 (+0.12), AMGN: 162.38 (-0.71), ABBV: 63.80 (+0.01)
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt
PR Newswire - Mon Oct 20, 7:40AM CDT
Investor-Edge has initiated coverage on the following equities: Allergan Inc. (NYSE: AGN), Zoetis Inc. (NYSE: ZTS), Actavis PLC (NYSE: ACT), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), and Mallinckrodt PLC (NYSE: MNK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 17, 2014, the NASDAQ Composite ended at 4,258.44, up 0.97%, the Dow Jones Industrial Average advanced 1.63%, to finish the day at 16,380.41, and the S&P 500 closed at 1,886.76, up 1.29%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 707.88, up 1.61%, with the index also advancing 0.29% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
MNK: 93.65 (+0.42), ZTS: 43.29 (+3.13), AGN: 195.82 (+0.58), AVNR: 13.32 (+0.10), ACT: 244.02 (-1.71)
Approval of Settlement, Philanthropic Activities, Partnership, Market Activity, and Dividend - Research Reports on Duke Energy, Lowe's, Viacom, Trinity and Zoetis
PR Newswire - Wed Oct 08, 8:20AM CDT
Today, Analysts Review released its research reports regarding Duke Energy Corp. (NYSE: DUK), Lowe's Companies, Inc. (NYSE: LOW), Viacom, Inc. (NASDAQ: VIAB), Trinity Industries Inc. (NYSE: TRN) and Zoetis Inc. (NYSE: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7017-100free.
ZTS: 43.28 (+3.12), DUK: 82.59 (-0.22), TRN: 35.98 (-0.04), LOW: 57.99 (+0.16), VIAB: 69.49 (-0.60)
Zoetis' board announces dividend of USD0.072 per share for Q4 2014
M2 - Fri Oct 03, 4:23AM CDT
The board of directors of Zoetis (NYSE:ZTS), an animal health company, on Friday declared a fourth quarter dividend of USD0.072 per share of the company's common stock.
ZTS: 43.28 (+3.12)
Zoetis Declares Fourth Quarter 2014 Dividend
Business Wire - Thu Oct 02, 4:10PM CDT
The Board of Directors of Zoetis Inc.(NYSE:ZTS) declared a fourth quarter dividend payable to holders of the company's common stock of $0.072 per share. The dividend is to be paid on Tuesday, Dec. 2, 2014, to holders of record on Wednesday, Nov. 5, 2014.
ZTS: 43.30 (+3.14)
